AR and prostate cancer: Treatment of the PC-3/AR prostate cancer cell line, which overexpresses AR [34], with dihydrotestosterone (DHT) induced endogenous ZEB1 mRNA and protein, confirming our observations that androgen increases ZEB1 mRNA and showing for the first time that this is reflected in ZEB1 protein levels.